In this article, we will take a look at the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds.
Nanotechnology, a groundbreaking concept introduced by Nobel Prize-winning physicist Richard Feynman in 1959 during a speech at Caltech, focuses on working with materials at an incredibly small scale—between one and 100 nanometers. At the nanoscale, things get interesting—surface area and quantum effects start playing a big role in how materials behave. Nanotechnology thus focuses on understanding and harnessing these unique properties, covering all kinds of research and technologies that take advantage of them.
Small Science VS Big Impact
One of the most exciting applications of nanotechnology is in the semiconductor industry. Today’s cutting-edge chips, like those powering iPhones and AI processors, rely on transistors that are just a few nanometers wide. Nanotechnology also plays a crucial role in improving semiconductor manufacturing, with specialized coatings and treatments that enhance equipment durability and efficiency, cutting downtime and boosting output.
Healthcare is another sector transformed by nanotechnology, becoming a cornerstone of modern biomedicine. From improving cancer diagnosis to enabling targeted drug delivery and advancing pharmaceutical manufacturing, it’s transforming the quality of treatments and boosting patient outcomes. This progress has led to the rise of nanomedicine, a field focused on innovative diagnostics, disease prevention, and streamlined drug development. In drug delivery, nanoscale technologies enhance how medications work by improving their stability and effectiveness. Perhaps the most exciting breakthrough is nanorobots—tiny machines that can travel through the bloodstream to deliver drugs precisely where they’re needed. This approach not only boosts precision but also reduces side effects, paving the way for more personalized and efficient treatments.
In the U.S., the National Nanotechnology Initiative (NNI) drives much of the research and development in this field. With participation from 30 federal agencies, the program underscores nanotechnology’s growing importance. The NNI’s 2024 budget request of $2.16 billion—the largest yet—focuses on both fundamental research and real-world applications. Given the trade tensions with China, which leads the world in nanotech startups, this investment is likely to grow, highlighting the strategic value of staying at the forefront of nanotechnology innovation.
The potential of nanotechnology is enormous. The global market is projected to soar to $33.63 billion by 2030, growing at an impressive 36.4% annually, according to Allied Market Research. Some sub-segments are expanding even faster—like the graphene market, expected to grow at 46.6% annually, and lipid nanoparticles, projected to rise at a 13.6% CAGR through 2029. With that, let’s take a look at the best nanotechnology stocks to invest in.
Our Methodology
To create our list of the Best Nanotechnology Stocks to Buy, we began by identifying companies with a strong presence in nanotechnology and its related industries. We explored ETFs and online resources to compile an initial pool of candidates. From there, we narrowed the list by analyzing hedge fund interest, using data from Insider Monkey’s Q3 2024 database, which tracks the activity of 900 hedge funds.
Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
12. Bruker Corporation (NASDAQ:BRKR)
Number of Hedge Fund Holders: 31
Bruker Corporation (NASDAQ:BRKR), a leading American manufacturer of high-performance scientific instruments, specializes in tools for molecular and materials research as well as industrial analysis. Its advanced analytical and diagnostic solutions support life sciences, pharmaceuticals, and industrial applications, enabling exploration at molecular, cellular, and microscopic levels. Bruker’s diverse product portfolio, including BIOSPIN instruments and elemental analyzers, has made it a cornerstone of the biochemical nanotechnology sector, with its equipment playing a critical role across the industry.
On December 19, Guggenheim initiated coverage of Bruker Corporation (NASDAQ:BRKR) with a Buy rating and a price target of $72. The firm praised Bruker’s leadership in its field, particularly highlighting the scientific rigor of its proteomics tools. Guggenheim expressed optimism about Bruker’s future, citing its strengthened market position and potential for revenue growth that outpaces peers, alongside significant margin expansion.
Bruker’s recent acquisitions of Chemspeed, NanoString, and ELITech reflect its strategic focus on growth areas such as spatial biology, molecular diagnostics, and laboratory automation. These moves align with its broader aim of enhancing innovation and expanding its capabilities.
In Q3 2024, Bruker Corporation (NASDAQ:BRKR) reported a 16.4% year-over-year revenue increase, reaching $864.4 million, driven by organic growth and contributions from recent acquisitions. However, the company revised its full-year guidance downward, citing slower-than-expected recoveries in the biopharma sector and weaker demand in the Chinese market.
11. PPG Industries Inc. (NYSE:PPG)
Number of Hedge Fund Holders: 32
PPG Industries Inc. (NYSE:PPG), a leader in the coatings industry, has long leveraged nanotechnology in its product development. The company integrates nanoparticles developed in-house into its advanced coatings, including those for the aerospace sector. These coatings offer features such as erosion resistance, ultraviolet light blocking, electromagnetic shielding, and compatibility with night vision systems, showcasing PPG’s innovation in vacuum and polymer coating technology.
Citi reaffirmed its Buy rating on PPG Industries Inc. (NYSE:PPG) on December 3, maintaining a price target of $150. PPG’s management remains optimistic about its outlook heading into 2025, highlighting strong performance in key areas like Comex, Aerospace, Packaging, and Protective & Marine coatings. While the automotive sector poses uncertainties, PPG is well-positioned to benefit from its robust partnerships with Chinese original equipment manufacturers (OEMs). General industrial activity shows mixed signals, but the company anticipates stable to modest growth across segments in 2025.
In Q3 2024, PPG Industries Inc. (NYSE:PPG) posted a profit of $468 million, or $2 per share, up from $426 million, or $1.79 per share, in the same period last year. Adjusted earnings per share rose to $2.13, compared to $2.07 in the previous year. However, revenue dipped 1.5% year-over-year to $4.57 billion, driven by weaker global industrial production that impacted demand in the Industrial Coatings segment.
